High Plasma Human Atrial Natriuretic Peptide and Reduced Transthoracic Left Atrial Appendage Wall-Motion Velocity Are Noninvasive Surrogate Markers for Assessing Thrombogenesis in Patients with Paroxysmal Atrial Fibrillation

Background The clinical relevance of examining human atrial natriuretic peptide (HANP) or left atrial appendage (LAA) wall‐motion velocity during sinus rhythm in paroxysmal atrial fibrillation (AF) patients has not been clearly elucidated. Methods The subjects were 38 patients with paroxysmal AF who...

Full description

Saved in:
Bibliographic Details
Published inEchocardiography (Mount Kisco, N.Y.) Vol. 31; no. 8; pp. 965 - 971
Main Authors Yoshida, Naoyasu, Okamoto, Mitsunori, Hirao, Hidekazu, Suenari, Kazuyoshi, Nanba, Kiyomi, Uchida, Mio, Yamazato, Ryo, Watari, Yuichiro, Fukuda, Yukihiro, Ueda, Hironori
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The clinical relevance of examining human atrial natriuretic peptide (HANP) or left atrial appendage (LAA) wall‐motion velocity during sinus rhythm in paroxysmal atrial fibrillation (AF) patients has not been clearly elucidated. Methods The subjects were 38 patients with paroxysmal AF who underwent transesophageal and transthoracic echocardiography during sinus rhythm. The presence of spontaneous echocontrast (SEC) was examined with transesophageal echocardiography and LAA wall‐motion velocity (LAAWV) was measured with transthoracic tissue Doppler echocardiography. Plasma HANP was measured within 3 hours after echocardiography. Results Human atrial natriuretic peptide ranged from 12 to 106 pg/mL with an average of 43 ± 24 pg/mL and had a significant correlation with LAAWV (r = −0.57) or LAA flow velocity (r = −0.41). HANP was significantly higher in patients with SEC than in patients without SEC (64 ± 29 vs. 34 ± 15 pg/mL, P = 0.008) and LAAWV was significantly lower in patients with SEC than in patients without SEC (13 ± 5 vs. 20 ± 5 cm/sec, P = 0.002). HANP >44 pg/mL had a sensitivity of 73% and specificity of 89% for diagnosing SEC. SEC was more frequently observed (73%) in patients with HANP >44 pg/mL and/or LAAWV <10 cm/sec as compared with patients (11%) with normal HANP and LAA wall‐motion velocity (P < 0.0001). Conclusion Higher plasma HANP and lower LAA wall‐motion velocity may be noninvasive surrogate markers for assessing left atrial thrombogenesis during sinus rhythm in paroxysmal AF patients.
Bibliography:ark:/67375/WNG-XWWWP1HP-W
istex:48F0DBF50F3B44CEB21F13CF462E18F6D338D763
ArticleID:ECHO12501
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0742-2822
1540-8175
1540-8175
DOI:10.1111/echo.12501